Open AccessCorrection: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
Author(s) -
Lihui Qu,
Yingying Lu,
Meike Ying,
Bingjue Li,
Chunhua Weng,
Zhoutao Xie,
Ludan Liang,
Chuan Lin,
Xiàn Yáng,
Shi Feng,
Yucheng Wang,
Xiujin Shen,
Qin Zhou,
Ying Chen,
Zhimin Chen,
Jianyong Wu,
Weiqiang Lin,
Yi Shen,
Jing Qin,
Hang Xu,
Feng Xu,
Junwen Wang,
Jianghua Chen,
Hong Jiang,
Hongfeng Huang
Publication year - 2020
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.27561
Subject(s) - tacrolimus , medicine , renal transplant , cyp3a5 , genotype , pharmacogenetics , oncology , bioinformatics , pharmacology , transplantation , urology , biology , genetics , gene
[This corrects the article DOI: 10.18632/oncotarget.18150.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom